期刊文献+

累及皮肤的套细胞淋巴瘤一例

Mantle cell lymphoma with skin involvement: a case report
原文传递
导出
摘要 患者女,51岁,确诊套细胞淋巴瘤20个月,四肢红色结节10 d.体检:左颈部及颌下区淋巴结肿大.双侧扁桃体Ⅱ度肿大.左上肢皮损组织病理示真皮及皮下组织见弥漫小淋巴细胞浸润,免疫组化示CD5、bcl-2、CD43、CD20、CyclinD1、λ均阳性,Ki-67阳性率>70%,CD3、C10、bcl-6、CD23、CD21、κ均阴性.荧光原位杂交检测示t(11∶14)CCND1/IGH融合基因阴性.诊断:累及皮肤的套细胞淋巴瘤.治疗:给予环磷酰胺+多柔比星+长春新碱+泼尼松方案治疗,病情控制,随访中. A 51-year-old female patient,who had been diagnosed with mantle cell lymphoma for 20 months,was admitted to the hospital for erythematous nodules on extremities for 10 days.Physical examination showed left cervical and submaxillary lymphadenectasis as well as bilateral enlarged palatine tonsils (grade Ⅱ).Histopathological examination of skin lesions on the left upper limb revealed diffuse infiltration of small lymphocytes in dermis and subcutaneous tissue.Immunohistochemical examination showed positive staining for CD5,Bcl-2,CD43,CD20,CyclinD1,λ chain and Ki-67 (〉 70 %),but negative staining for CD3,C10,Bcl-6,CD23,CD21 and κ chain.Fluorescence in situ hybridization (FISH) showed the absence of the t(11:14)/CCND1-IGH fusion gene.The patient was diagnosed as mantle cell lymphoma with skin involvement.After treatment with cyclophosphamide,doxorubicin,vincristine and prednisone,the condition was controlled and follow up was underway.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2015年第1期50-52,共3页 Chinese Journal of Dermatology
关键词 淋巴瘤 套细胞 皮肤疾病 少见病 Lymphoma,mantle-cell Skin diseases Rare diseases
  • 相关文献

参考文献7

  • 1Sonmez M, ';:obanoglu 0, Karyagar S, et al. FDG-PET in mantle cell lymphoma involving skin [J]. Turk J Hematol, 2010, 27(4): 324-325.
  • 2Fu K, Weisenburger DD, Greiner TC, et al. Cyclin Dl-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling[J]. Blood, 2005, 106(13): 4315-4321.
  • 3Ek S, Dictor M, Jerkeman M, et al. Nuclear expression of the nonB-cell lineage Soxl1 transcription factor identifies mantle cell lymphoma[J]. Blood, 2008,111(2): 800-805.
  • 4Canpolat F, Tas E, Sonmez A A, et al. Cutaneous presentation of mantle cell lymphoma [J]. Acta Derm Venereol, 2010, 90 (5): 548-550.
  • 5Ishibashi M, Yamamoto K, Kudo S, et al. Mantle cell lymphoma with skin invasion characterized by the common variant in the subcutis and blastoid transformation in the overlying dennis [J]. Am J Dennatopathol, 2010, 32(2): 180-182.
  • 6朱军,应志涛.套细胞淋巴瘤诊治新进展[J].中国肿瘤临床,2011,38(18):1067-1070. 被引量:6
  • 7马寒,童秀珍,苏畅,李娟,陆春.累及皮肤的套细胞淋巴瘤一例[J].中华皮肤科杂志,2012,45(8):592-594. 被引量:1

二级参考文献38

  • 1刘薇,王迎,邱录贵.套细胞淋巴瘤的治疗进展[J].中华血液学杂志,2006,27(10):710-712. 被引量:3
  • 2Chandran R,Gardiner SK,Simon M,et al.Survival trends in mantle cell lymphoma in the United States over 16 years,1992-2007[J].J Clin Oncol,2011,29(Suppl):abstract e18530.
  • 3Fu K,Weisenburger DD,Greiner TC,et al.Cyclin D1-negative mantle cell lymphoma:a clinicopathology study based on gene expression profiling[J].Blood,2005,106(13):4315-4321.
  • 4Ek S,Dictor M,Jerkeman M,et al.Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma[J].Blood,2008,111(2):800-805.
  • 5Hoster E,Dreyling M,Klapper W,et al.A new prognostic index(MIPI) for patients with advanced-stage mantle cell lymphoma[J].Blood,2008,111(2):558-565.
  • 6Hoster E,Unterhalt M,Wommann B,et al.The addition of rituximab to first-line chemotherapy(R-CHOP) results in superior response rates,time to treatment failure and response duration in patients with advanced stage mantle cell lymphoma:long term results of a randomized GLSG trial[J].Blood,2008,112:16.
  • 7Dreyling MH,Griffiths R,Gleeson M,et al.Improved overall survival after the addition of rituximab to chemotherapy alone as first-line therapy for mantle cell lymphoma (MCL):Evidence from SEER-Medicare[J].J Clin Oncol,2011,29(Suppl):abstract e18500.
  • 8Balta A,Panitsas F,Skertsou M,et al.First line treatment with anthracycline-based regimen with or without rituximab in patients with mantle cell lymphoma[J].Ann Oncol,2011,22 Suppl 4:iv220.
  • 9Romaguera JE,Khouri IF,Kantarjian HM,et al.Untreated aggressive mantle cell lymphoma:results with intensive chemotherapy without stem cell transplant in elderly patients[J].Leuk Lymphoma,2000,39(1-2):77-85.
  • 10Merli F,Luminari S,Llariuvvi F,et al.Rituximab plus hyper CVAD alternating with high dose methotrexate and cytarabine for patients with newly diagnosed mantle cell lymphoma.A multicenter trial from GISL[J].Ann Oncol,2011,22 Suppl 4:iv162.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部